Sulfamethoxazole-Trimethoprim

Overview

No overview information available.

Indication

⑴由对该合剂呈现敏感的流感嗜血杆菌或肺炎链球菌所致的慢性支气管炎急性发作； ⑵由敏感流感嗜血杆菌或肺炎链球菌所致的儿童急性中耳炎； ⑶由大肠埃希菌、克雷伯菌属、肠杆菌属、奇异变形杆菌、普通变形杆菌和摩根菌敏感菌珠所致的细菌性尿路感染； ⑷由产肠毒素大肠埃希菌和志贺菌属所致的旅游者腹泻； ⑸由福氏或宋氏志贺菌敏感菌珠所致的志贺菌感染； ⑹由奴卡菌（罗卡菌）、星形诺卡菌引起的感染； ⑺治疗卡氏肺孢子菌肺炎（（也称卡氏肺孢子虫肺炎(PCP肺炎)），该药系首选药，喷他脒为替代选用药； ⑻卡氏肺孢菌肺炎的预防，用于免疫缺陷者卡氏肺孢菌病发病危险性增长时，即可用于下列两种情况：已经有卡氏肺孢菌病至少一次的发作史的患者，另一种为艾滋病毒（HIV）成人感染者，其CD4淋巴细胞计数≤200/mm³或少于总淋巴细胞数的20％。下列情况不宜应用本品：①中耳炎的预防和长程治疗；②A组溶血性链球菌扁桃体炎和咽炎。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
S. Aureus Decolonization in HPN Patients.	2017/06/01	NCT03173053	Not Applicable	Terminated	Radboud University Medical Center
Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma	2015/12/08	NCT02624440	Phase 2	UNKNOWN	Henrik Gregersen
Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations	2010/07/22	NCT01167452	Phase 4	Completed	Texas Tech University Health Sciences Center
A Randomized Controlled Trial on Antibiotic Prophylaxis in Children With Vesico-Ureteral Reflux	2006/09/29	NCT00382343	Phase 4	Completed	IRCCS Burlo Garofolo
Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media	2005/09/16	NCT00189098	Not Applicable	Completed	UMC Utrecht
Prophylactic Antibiotics in Measles	2005/09/15	NCT00168532	Phase 3	Completed	Bandim Health Project
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites	2001/08/31	NCT00000826	Phase 1	Completed	National Institute of Allergy and Infectious Diseases (NIAID)
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients	2001/08/31	NCT00000748	Phase 3	Completed	National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients	2001/08/31	NCT00000991	Phase 3	Completed	National Institute of Allergy and Infectious Diseases (NIAID)
Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine	2001/08/31	NCT00000734	Not Applicable	Completed	National Institute of Allergy and Infectious Diseases (NIAID)

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access